Search filters

List of works by Sjoerd Rodenhuis

A gene-expression signature as a predictor of survival in breast cancer

scientific article (publication date: 19 December 2002)

Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

scientific article

Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency

scientific article published on 23 April 2008

An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy

scientific article published in April 2011

An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment

scientific article published on 03 September 2008

Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism

scientific article

Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes

scientific article

Carbamazepine induces bioactivation of cyclophosphamide and thiotepa

scientific article published on 24 April 2008

Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?

scientific article

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer

scientific article published in May 2005

Clinical pharmacokinetics of cyclophosphamide

scientific article

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

scientific article published on 8 August 2009

Detection of circulating breast tumor cells by differential expression of marker genes

scientific article published on 01 June 2002

Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results

scientific article published on 01 November 2008

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla ⬇️

scientific article published on March 1, 2013

Effects of co-medicated drugs on cyclophosphamide bioactivation in human liver microsomes

scientific article published in March 2005

Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin

scientific article published on 30 July 2002

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer ⬇️

scientific article published on February 12, 2013

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study

scientific article

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

scientific article

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.

scientific article

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

scientific article

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

scientific article published on July 2003

Identifying subgroup markers in heterogeneous populations

scientific article published on 22 September 2013

Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review

scientific article

Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide

scientific article

Integrated Population Pharmacokinetic Model of both cyclophosphamide and thiotepa suggesting a mutual drug-drug interaction

scientific article published in April 2004

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

scientific article published on 8 September 2012

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy ⬇️

scientific article published on July 28, 2012

Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype ⬇️

scientific article published on January 10, 2011

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes

scientific article

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response

scientific article

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

scientific article published on 24 December 2015

Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer

scientific article

Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen

scientific article

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

article

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa

scientific article

Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin

scientific article published in December 2005

Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL

scientific article published on March 2005

Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy

scientific article

Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement

scientific article published in July 2004

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

article by Stefan Sleijfer et al published January 2010 in European Journal of Cancer

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

scientific article published on December 2007

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness ⬇️

scientific article published on October 27, 2011

Recurrent upper respiratory tract infections during and after rituximab therapy

scientific article published on January 2015

Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin

scientific article

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer.

scientific article published in December 2012

Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy ⬇️

scientific article published on August 9, 2013

Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin

scientific article

Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospr

scientific article published in March 2004

Sparse sampling design for therapeutic drug monitoring of sequentially administered cyclophosphamide, thiotepa, and carboplatin (CTC).

scientific article published in June 2005

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

scientific article published on 05 August 2016

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

scientific article published on 13 February 2009

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.

scientific article

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

scientific article published on 26 November 2007

Paulina is supported by:

About Paulina

Help